close
Edit Metric
Company
Value
Source
Source URL
Notes
Cancel
 
close
Edit  |  History
Details
Company:
Value :
Source:
Source URL:
Notes:
 
Feedback
Get involved
FAQ

See all Bulls Reasons
Bulls: Reasons To Buy

line

Best of breed stereotactic robotic radiosurgery system for cancer treatments

CyberKnife is the only radiosurgery machine approved by the FDA for all solid tumors: lung, prostate, liver, central nervous system (both brain and spinal cord), and pancreatic cancer. Key advantages of CyberKnife versus Hi-Art (Tomotherapy) and Trilogy (Varian): + minimizes... read more
2 votes
100%
agree

Long-term secular growth story

Cancer treatment is a long-term secular growth business as a result of the graying of the world population. Radiosurgery is a non-invasive alternative to surgery to excise tumors.
1 votes
100%
agree

See all Bears Reasons
Bears: Reasons To Sell

line

Large ticket item in current credit contrained environment

CyberKnife is a $4-5M purchase which could be deferred as hospitals face financing difficulty in the current credit markets.
1 votes
100%
agree

Send the authors a comment or suggestion

line
Be the first to make a suggestion

Top Contributors

We want you to contribute!
The article about this company has not been written yet. You could be the first person to write about this company—it's a sure thing that you'll be credited as a Top Contributor.


You may also be interested in articles related to Accuray (ARAY):



[edit] References

Retrieved from "http://www.wikinvest.com/stock/Accuray_(ARAY)"
The Shelf
Contributions
Help make Wikinvest better! Learn how to get involved. And create an account to build your reputation.
Did you know…?
Bookmarks
Worried about pump and dump?
We review changes
for stock spam
» read more
Want to make Wikinvest better?
We need your help,
contribute today
» learn how
Do you write software?
We are recruiting
the best engineers
» view jobs
Like Wikinvest?
Spread the word —
Tell your friends!
» spread the word
Wikinvest © 2006, 2007, 2008. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki